Olivia Putri Chairunnisa, Mia Audina and Irawati (trans.) (2025) “Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review”, The Indonesian Journal of General Medicine, 12(3), pp. 1–48. doi:10.70070/vbsedq58.